Publication | Closed Access

Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients

InflammationLow Density LipoproteinHypercholesterolemic PatientsCardiovascular DiseaseMedicineLipid-lowering TherapyHyperlipidemiaVascular BiologyLipoprotein MetabolismPharmacologyAtherosclerosisDyslipidemiaOxidative Stress